Detailed Narrative
Strong H1 FY26 Financial Performance
Asarfi Hospital delivered robust financial results for H1 FY26, with revenue from operations surging 50% year-on-year to ₹80.6 crores. EBITDA grew 38% YoY to ₹15.86 crores, maintaining a healthy 20% margin. Net profit (PAT) saw an even more significant increase of 70% YoY, reaching ₹7.32 crores, and the PAT margin improved to 9%.
Operational Growth and Capacity Expansion
The company's Superspeciality Hospital achieved a 64% occupancy rate and an ARPOB of ₹19,839. The newly operational cancer hospital, the first of its kind in Dhanbad, saw its occupancy improve from 26% to 44% in H1 FY26, with its ARPOB more than doubling to ₹41,401. Overall, in-patient volume more than doubled to 12,361, and out-patient volume increased to 72,317 from 54,000 in the prior period. An additional 65 beds are expected to be operational before March 2026 with a CAPEX of less than ₹3 crores.
Strategic Initiatives and Partnerships
Asarfi Hospital has entered into a strategic MoU with Gleneagles Hospital, Chennai, to establish Jharkhand's multi-organ transplant unit, aiming to provide world-class services locally. The company also plans to launch a Bone Marrow Transplant Unit next year and operationalize an education vertical with a 600-plus capacity hospital and healthcare management institute in Ranchi. Furthermore, discussions are ongoing for a cashless merger with a 70-bed promoter entity hospital to further expand capacity.
Addressing Trade Receivables and Profitability
A key challenge highlighted was the 67% YoY growth in trade receivables, primarily due to delayed payments from government agencies (90-180 days) and the new cancer hospital's initial reliance on cashless business. Management is actively working to reduce debtor days and improve cash flow. To enhance PAT margins to a target of 13-15%, the company is focusing on cost reduction, optimizing doctor contracts, and increasing the use of generic medicines for corporate and cashless patients.
Future Outlook and Long-Term Vision
Looking ahead, Asarfi Hospital targets ₹160 crores in revenue with a 13-15% PAT margin for FY26, and ₹200 crores in revenue for FY27. By 2027, the company aims for a total bed capacity of 500, an EBITDA margin of 25-27%, and a PAT margin of 13-15%. The long-term vision includes scaling the cancer hospital to 150 beds and aspiring to become a 1,000-bed company before 2030, primarily through brownfield projects funded by internal accruals.
Human Capital Management
The company acknowledged a 20-30% attrition rate, particularly in nursing, attributing it to factors such as young age, marriage, and government job opportunities. Management is reviewing HR policies and focusing on creating a conducive work environment to reduce attrition and ensure retention of skilled healthcare professionals.